NAS:INO (USA) Also Trade In: Germany Mexico UK

Inovio Pharmaceuticals Inc $ 9.19 0.04 (0.44%)

Volume:
14,399,142
Avg Vol (1m):
18,105,168
Market Cap $:
1.91 Bil
Enterprise Value $:
1.54 Bil
PE Ratio:
0.00
PB Ratio:
3.49
Warning! GuruFocus has detected 5 Severe warning signs with INO. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 10Y (-%)

Inovio Pharmaceuticals Inc News and Headlines -

GuruFocus Articles Total 14
  • 1

Nasdaq gains 1.87%

The Dow Jones Industrial Average closed at 27,584.06 on Monday with a gain of 410.10 points or 1.51%. The S&P 500 closed at 3,351.60 for a gain of 53.14 points or 1.61%. The Nasdaq Composite closed at 11,117.53 for a gain of 203.96 points or 1.87%. The VIX Volatility Index was lower at 26.19 for a loss of 0.19 points or -0.72%.

Monday's Market Movers

The major U.S. indexes continued a run higher, closing with gains for a third day. In morning trading, investors were pleased with economic data from China. U.S. trading also trended higher as most major global

44 Views    Julie Young    2020-09-29 13:44
Nasdaq up 18.94% for the year

The Dow Jones Industrial Average closed at 27,173.96 on Friday with a gain of 358.52 points or 1.34%. The S&P 500 closed at 3,298.46 for a gain of 51.87 points or 1.60%. The Nasdaq Composite closed at 10,913.56 for a gain of 241.30 points or 2.26%. The VIX Volatility Index was lower at 26.38 for a loss of 2.13 points or -7.47%.

For the week, the Nasdaq gained 1.2%, the S&P 500 was down -0.6% and the Dow Jones was down -1.7%. For the year, the Nasdaq has a gain of 18.94%, the S&P 500 is up 2.09% and the

63 Views    Julie Young    2020-09-27 12:35
Nasdaq down 1.27%

The Dow Jones Industrial Average closed at 27,901.98 on Thursday with a loss of 130.40 points or -0.47%. The S&P 500 closed at 3,357.01 for a loss of 28.48 points or -0.84%. The Nasdaq Composite closed at 10,910.28 for a loss of 140.19 points or -1.27%. The VIX Volatility Index was higher at 26.46 for a gain of 0.42 points or 1.61%.

Thursday's market movers

U.S. indexes closed lower Thursday. Selling continued to follow the Federal Reserve's Wednesday meeting releases, which showed an extended outlook for economic challenges. Technology, which has been the market's sector leader year to date, was

125 Views    Julie Young    2020-09-17 21:13
While giants like Gilead Sciences and Pfizer are progressing well, many small players have witnessed setbacks in their Covid-19 research

As the world awaits a potential solution to counter the Covid-19 pandemic, a number of pharma and biotech companies have their candidates going through different stages of trials.

The total number of confirmed Covid-19 cases across the globe is nearing the 12 million mark, with over 3 million in the U.S. alone. Governments have thus been putting increasing pressure on scientists and pharmaceutical companies to come up with a drug or a vaccine to handle the situation. The process has been slow, which was expected as a successful treatment has never before been developed for any other type of coronavirus,

245 Views    Ishan Majumdar    2020-07-08 20:50
Several first-quarter buys showing triple-digit price increases from average

According to Consensus Picks, a GuruFocus premium feature, several first-quarter guru buys have seen their prices increase at triple-digit percentages from average. Holdings with the largest growth to present include LightPath Technologies Inc. (LPTH), Fastly Inc. (FSLY), Inovio Pharmaceuticals Inc. (INO), Schrodinger Inc. (SDGR) and ACM Research Inc. (ACMR).

LightPath Technologies

In the first quarter, gurus Jim Simons (Trades, Portfolio)' Renaissance Technologies and Chuck Royce (Trades, Portfolio) both added to their positions in LightPath Technologies at an average price of 99 cents per share. Since the end of the first quarter, each

574 Views    Graham Griffin    2020-06-17 21:10
After making progress in drug or vaccine trials for Covid-19, these stocks have seen triple-digit growth

There are two distinct approaches that are being adopted by research-focused biopharma companies to counter the Covid-19 pandemic. Some companies are focused on developing vaccines for preventive purposes, whereas others are more focused on drug development to cure the patients who are suffering from the virus.

While giants like Gilead Sciences (GILD) and Sanofi (SNY) are making progress in the development of a drug and vaccine, respectively, a number of small research-focused players have emerged whose candidates are demonstrating promising results in the early phases of testing, causing their stock prices to increase dramatically.

Sorrento Therapeutics

Sorrento Therapeutics (SRNE) is

512 Views    Ishan Majumdar    2020-05-20 22:30
The research-focused biopharma player has made progress in developing and testing

Biotech and pharma companies all over the world are engaged in the development and testing process of their respective drug and vaccine candidates to counter the Covid-19 pandemic.

While companies like Inovio Pharmaceuticals (INO) and Moderna (MRNA) have advanced rapidly on the vaccine development, others, such as Gilead Sciences (GILD) and NanoViricides (AMEX:NNVC), are more focused on the development of a treatment drug.

NanoViricides a relatively small, research-focused player that has been in the news ever since the company started the process of developing a Covid-19 treatment along with its other research on viral diseases such as herpes, shingles, seasonal

344 Views    Ishan Majumdar    2020-05-12 15:57
British company's shares up 35% this year as demand for health care information analysis grows

A London-based company has thrown some cold water on projections that there could be a vaccine for Covid-19 in 12 to 18 months. But that’s its job. And based on the performance of the company’s stock, investors have confidence the company knows what it is talking about.

Clarivate Analytics PLC's (CCC) shares are up more than 35% this year, to more than $23. The spotlight on the company's work has grown brighter due to the pandemic. It provides structured information and analytics for discovery, protection and commercialization of scientific research, innovations and brands.

Clarivate has studied the vaccines that are

347 Views    Barry Cohen    2020-04-19 18:54
Shares of several pharma and biotech companies are up sharply over the past month

In the past month, the pharmaceutical index has declined about half as much as the Dow Jones Industrial Average and the S&P 500. That’s logical considering science-based companies are those entities governments and the public are relying on to produce tests to detect the Covid-19 virus and, hopefully, develop a vaccine and a treatment.

Shares of one of the larger-cap companies, Regeneron (RGEN), are up about 25% in the past 30 days. The Tarrytown, New York-based company has had a relationship since 2014 with the Department of Health and Human Services’ Biomedical Advanced Research and Development Authority (BARDA). In early

385 Views    Barry Cohen    2020-03-18 19:24
With the spread of the new coronavirus from Wuhan, investors should consider investing in smaller biotech and pharma players

The U.S. stock indices are filled with small pharma and biotech stocks that are purely research-oriented. Most of these companies don’t even have revenues and are entirely focused on building a strong pipeline of drugs and vaccines to counter various diseases that are affecting mankind.

The problem with these companies is that their low or nonexistent revenues result in a weak investor perception as the qualitative benefits of their research cannot be measured tangibly. However, with the outbreak of the Wuhan coronavirus, the importance of investing in the research of such companies is suddenly a hot topic in the investor

396 Views    Ishan Majumdar    2020-02-18 18:01

The CEO of Inovio Pharmaceuticals Inc (INO), Jong Joseph Kim, purchased 250,000 shares for $2,265,000 on August 12. The average price per share was $9.06.

Inovio was down 8% on its quarterly earnings, which the company reported before the market opened Tuesday. The company announced that it is planning to begin phase 3 trials for its lead vaccine prospect, VGX-3100. Phase 3 is the next-to-last phase in a drug’s clinical trials.

VGX-3100 is being developed as a non-surgical treatment for cervical pre-cancers. In phase 2 trials the treatment either reduced cervical intraepithelial neoplasia 2/3 (CIN2/3) to CIN1 or removed it.

539 Views    David Goodloe    2014-08-13 18:29
According to [url=http://www.gurufocus.com/InsiderBuy.php]GuruFocus Insider Data[/url], these are the largest CEO buys during the past week. The overall trend of CEOs is illustrated in the chart below: [b]Independent Bank Group Inc. (IBTX): Chairman and CEO David R. Brooks Bought 4,192 Shares[/b] Chairman and CEO of Independent Bank Group Inc. (IBTX) David R. Brooks bought 4,192 shares on April 3, 2013 at an average price of $28.6. Independent Bank Group Inc. has a market cap of $328.034 million; its shares were traded at around $28.6 with a P/E ratio of 12.8205 and a P/S ratio
412 Views    GuruFocus    2013-04-07 21:34
According to [url=http://www.gurufocus.com/InsiderBuy.php]GuruFocus Insider Data[/url], these are the largest CFO buys during the past week. The overall trend of CFOs is illustrated in the chart below: [b]Zbb Energy Corp (ZBB): CFO William C Hogoboom Bought 28,947 Shares[/b] CFO of Zbb Energy Corp (ZBB) William C Hogoboom bought 28,947 shares on 06/14/2012 at an average price of $0.38. ZBB Energy Corporation develops and manufactures distributed energy storage solutions based on the Company's proprietary zinc-bromine rechargeable electrical energy storage technology. Zbb Energy Corp has a market cap of $15.5 million; its shares were traded at around
649 Views    gurujk    2012-06-17 16:30
According to [url=http://www.gurufocus.com/InsiderBuy.php]GuruFocus Insider Data[/url], these are the largest CFO buys during the past week. The overall trend of CFOs is illustrated in the chart below: [b]Broadwind Energy (BWEN): Executive Vice President and CFO Stephanie K. Kushner Bought 100,000 Shares[/b] Executive Vice President and CFO of Broadwind Energy (BWEN) Stephanie K. Kushner bought 100,000 shares on 06/04/2012 at an average price of $0.26. Broadwind Energy Inc., headquartered in Naperville, Ill., owns, supports, grows and strategically positions companies that manufacture, install and maintain components for the energy industry, with a primary emphasis on the
714 Views    gurujk    2012-06-11 15:10

Headlines Total 280
  • 1
  • 2
  • 3

2021-03-02 $ 10.02 (-13.62%)
11:27am
6:02am
1:13am
2021-02-26 $ 11.1 (-3.39%)
7:50am
2021-02-22 $ 12.88 (-6.94%)
11:30am
9:25am
2021-02-21
6:26am
2021-02-19 $ 13.84 (-0.93%)
4:45pm
2021-02-12 $ 14.22 (9.38%)
11:17am
2021-02-07
6:55am
2021-02-04 $ 14.56 (-3.51%)
7:15pm
2021-01-31
11:17am
2021-01-30 $ 12.75 (16.44%)
7:15pm
2021-01-28 $ 10.95 (-12.4%)
1:40pm
6:04am
2021-01-21 $ 9.1 (-6.38%)
12:00pm
2021-01-17
9:40am
2020-12-30 $ 9 (0.9%)
7:02am
2020-12-28 $ 9.6 (-6.43%)
4:05pm
8:30am
2020-12-24 $ 10.26 (1.89%)
9:08am
2020-12-17 $ 10.72 (2.68%)
7:51am
2020-12-13
2:40pm
2020-12-03 $ 12.52 (4.59%)
5:53pm
2020-12-01 $ 12.42 (1.64%)
7:00am
2020-11-30 $ 12.22 (-0.33%)
12:56pm
2020-11-27 $ 12.26 (18%)
11:23am
8:11am
2020-11-20 $ 10.54 (-4.36%)
3:56pm
8:08am
11:11pm
2020-11-19 $ 11.02 (-0.18%)
9:50am
2020-11-18 $ 11.04 (-5.64%)
4:48am
2020-11-17 $ 11.7 (-8.95%)
3:50pm
1:55pm
8:33am
2020-11-16 $ 12.85 (14.53%)
12:11pm
2020-11-12 $ 11.36 (5.97%)
8:55am
7:35am
2020-11-11 $ 10.72 (-6.86%)
6:53am
5:55am
2020-11-10 $ 11.51 (35.41%)
6:08am
11:34pm
2020-11-08
7:12am
2020-11-07
6:55am
2020-11-04 $ 10.91 (6.75%)
6:25am
2020-10-31
5:51am
2020-10-28 $ 10.92 (-1.71%)
11:58am
2020-10-27 $ 11.11 (6.32%)
7:07am
2020-10-24
6:30am
2020-10-18
9:04am
2020-10-17
7:40am
2020-10-12 $ 12.43 (0.97%)
6:42am
2020-10-10
7:00am
5:51am
2020-10-07 $ 12.58 (1.37%)
9:10am
2020-10-06 $ 12.41 (3.94%)
6:12am
2020-10-05 $ 11.94 (2.49%)
6:06am
2020-10-04
8:07am
6:38am
2020-10-03
8:20am
2020-09-28 $ 12.14 (-28.34%)
4:03pm
3:13pm
10:04am
2020-09-27
5:30pm
2020-09-26
7:36am
2020-09-23 $ 15.97 (-5.95%)
2:06pm
11:50am
7:03am
2020-09-22 $ 16.98 (-4.01%)
6:04am
2020-09-20
7:15am
2020-09-19
8:25am
2020-09-18 $ 17 (8.49%)
11:49am
2020-09-17 $ 15.67 (-15.39%)
1:35pm
10:36am
2020-09-16 $ 18.52 (35.88%)
6:59pm
11:32am
2020-09-15 $ 13.63 (20.41%)
5:04pm
11:31am
6:11am
2020-09-14 $ 11.32 (12.3%)
12:25pm
12:20pm
6:45am
2020-09-12
6:53am
2020-09-10 $ 9.72 (-5.4%)
9:02am
2020-09-09 $ 10.275 (6.92%)
11:43am
8:03am
7:08am
5:08am
2020-09-06
6:12am
2020-09-04 $ 9.57 (-2.84%)
10:53am
2020-09-03 $ 9.85 (-7.34%)
6:10am
2020-09-02 $ 10.63 (-6.84%)
5:23pm
6:37am
2020-09-01 $ 11.41 (-4.84%)
3:49pm
3:39pm
2020-08-29
8:08am
2020-08-27 $ 11.81 (-7.23%)
6:08am
2020-08-26 $ 12.73 (0.87%)
8:02am
7:34am
Total 280
  • 1
  • 2
  • 3